These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18318559)

  • 1. Gastro-oesophageal reflux disease in Asia : birth of a 'new' disease?
    Cheung TK; Wong BC; Lam SK
    Drugs; 2008; 68(4):399-406. PubMed ID: 18318559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of reflux symptoms and GORD.
    Ronkainen J; Agréus L
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):325-37. PubMed ID: 23998972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastro-oesophageal reflux disease in Asia.
    Goh KL; Chang CS; Fock KM; Ke M; Park HJ; Lam SK
    J Gastroenterol Hepatol; 2000 Mar; 15(3):230-8. PubMed ID: 10764021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
    Rosaida MS; Goh KL
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.
    Fock KM; Talley N; Goh KL; Sugano K; Katelaris P; Holtmann G; Pandolfino JE; Sharma P; Ang TL; Hongo M; Wu J; Chen M; Choi MG; Law NM; Sheu BS; Zhang J; Ho KY; Sollano J; Rani AA; Kositchaiwat C; Bhatia S
    Gut; 2016 Sep; 65(9):1402-15. PubMed ID: 27261337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the diagnosis and management of GORD in adults.
    Hopper AD
    Practitioner; 2015 Apr; 259(1781):27-32, 3. PubMed ID: 26529827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and natural history of gastro-oesophageal reflux disease.
    Spechler SJ
    Digestion; 1992; 51 Suppl 1():24-9. PubMed ID: 1397743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease.
    Hungin AP; Raghunath AS; Wiklund I
    Fam Pract; 2005 Dec; 22(6):591-603. PubMed ID: 16024554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of gastro-oesophageal reflux disease: a systematic review.
    Dent J; El-Serag HB; Wallander MA; Johansson S
    Gut; 2005 May; 54(5):710-7. PubMed ID: 15831922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
    Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
    Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers.
    El-Serag HB; Satia JA; Rabeneck L
    Gut; 2005 Jan; 54(1):11-7. PubMed ID: 15591498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of proton pump inhibitors in gastro-oesophageal reflux disease.
    Dekel R; Morse C; Fass R
    Drugs; 2004; 64(3):277-95. PubMed ID: 14871170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of gastro-oesophageal reflux disease.
    Parasa S; Sharma P
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):433-42. PubMed ID: 23998980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
    Orr WC
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):113-20. PubMed ID: 15647651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.